FDA Adverse Event Other Summary report: N

UNK

MDR report key: 2945081 · Received February 1, 2013

Report

Report Number
9611165-2013-00007
Event Type
Other
Date Received
February 1, 2013
Report Date
January 14, 2013
Manufacturer
RAYNER INTRAOCULAR LENSES LIMITED
Product Code
HQL
PMA / PMN Number
P060011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE REFERENCE (B)(4) HAS BEEN ALLOCATED TO THIS EVENT BY RAYNER INTRAOCULAR LENSES LIMITED. THE HEALTHCARE PROFESSIONAL INTENDS TO PERFORM A YAG CAPSULOTOMY. NO FURTHER INFO ON THE PROPOSED CORRECTIVE ACTION AND/OR THE RESULTS OF THIS ACTION HAS BEEN PROVIDED TO RAYNER. RAYNER SOUGHT CLINICAL FEEDBACK FROM THE CLINICAL ADVISORY TEAM ON THE REPORTED EVENT AND RECEIVED THE FOLLOWING RESPONSE; "ANY BSS LEFT BEHIND AN IOL WILL RAPIDLY BE REPLACED BY AQUEOUS. MY EXPERIENCE IS THAT AS THE CAPSULE CONTRACTS (OVER A FEW WEEKS MAXIMUM) THIS POTENTIAL SPACE DISAPPEARS EXCEPT WHEN THE SURGEON LEAVES OVD BEHIND THE IOL. IF THE IOL BLOCKS THE CAPSULORRHEXIS, THEN YOU HAVE THE SCENARIO FOR CAPSULAR BLOCK SYNDROME, AND THE OVD WILL DEGRADE AND BECOME CLOUDY. THIS WOULD EXPLAIN WHY THIS SURGEON IS HAVING A SERIES OF CASES; SHE IS NOT USING THE "ROCK AND ROLL" MANEUVER INTRAOPERATIVELY TO DISPLACE OVD FOR BEHIND THE IOL." WITHOUT THE ABILITY TO EXAMINE THE DEVICE AND WITHOUT CLEAR EVENT DETAILS BEING PROVIDED A FAILURE MODE AND ROOT CAUSE CANNOT BE ASCERTAINED.

Description of Event or Problem · 1

RAYNER INTRAOCULAR LENSES LIMITED RECEIVED NOTIFICATION FROM THE (B)(6) REP OF AN EVENT THAT OCCURRED FOLLOWING THE IMPLANTATION OF A RAYNER INTRAOCULAR LENS (MODEL NUMBER UNK). THE EVENT DESCRIPTION PROVIDED INDICATES THAT THE HEALTHCARE PROFESSIONAL HAS REPORTED A SYMPTOMATIC REDUCTION IN THE QUALITY OF VISION OF A PT POST-OPERATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
45226 UNK HQL - INTRAOCULAR LENS HQL RAYNER INTRAOCULAR LENSES LIMITED UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention